125 related articles for article (PubMed ID: 7046903)
21. Multivariate analysis of T-cell functional defects and circulating serum factors in Hodgkin's disease.
Schulof RS; Bockman RS; Garofalo JA; Cirrincione C; Cunningham-Rundles S; Fernandes G; Day NK; Pinsky CM; Incefy GS; Thaler HT; Good RA; Gupta S
Cancer; 1981 Aug; 48(4):964-73. PubMed ID: 6456060
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease.
van Rijswijk RE; Sybesma JP; Kater L
Cancer; 1984 Jan; 53(1):62-9. PubMed ID: 6690004
[TBL] [Abstract][Full Text] [Related]
23. Impairment of lymphocyte transformation by plasma from patients with advanced Hodgkin's disease.
Sugden PJ; Lilleyman JS
Cancer; 1980 Mar; 45(5):899-905. PubMed ID: 7260841
[TBL] [Abstract][Full Text] [Related]
24. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
Churchill WH; Rocklin RR; Moloney WC; David JR
Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
[No Abstract] [Full Text] [Related]
25. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
Zółtowska A; Arendt M; Gan J
Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
[TBL] [Abstract][Full Text] [Related]
26. Normal active rosette-forming-cells in untreated patients with Hodgkin's disease.
Lang JM; Bigel P; Oberling F; Mayer S
Biomedicine; 1977 Dec; 27(9-10):322-4. PubMed ID: 606306
[TBL] [Abstract][Full Text] [Related]
27. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
Han T; Minowada J; Subramanian V; Barcos M; Kim U
Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of the changes in the immune status before, during, and after multiple-agent chemotherapy for Hodgkin's disease.
Van Rijswijk RE; Sybesma JP; Kater L
Cancer; 1983 Feb; 51(4):637-44. PubMed ID: 6821837
[TBL] [Abstract][Full Text] [Related]
29. Deficiency of lymphocyte antigen recognition in Hodgkin's disease.
Gaines JD; Gilmer MA; Remington JS
Natl Cancer Inst Monogr; 1973 May; 36():117-21. PubMed ID: 4744572
[No Abstract] [Full Text] [Related]
30. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
Fuks Z; Strober S; King DP; Kaplan HS
J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
[TBL] [Abstract][Full Text] [Related]
31. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
32. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
Babacan E; Cavdar AO; Arcasoy A
Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
[TBL] [Abstract][Full Text] [Related]
33. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
[TBL] [Abstract][Full Text] [Related]
34. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
[TBL] [Abstract][Full Text] [Related]
35. The Reed-Sternberg cell/lymphocyte rosette. I. Properties of rosettes formed between Hodgkin's cell lines and allogeneic lymphocytes.
Flavell DJ; Wright DH
Br J Cancer; 1989 Feb; 59(2):165-73. PubMed ID: 2495015
[TBL] [Abstract][Full Text] [Related]
36. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
Fuks Z; Strober S; Kaplan HS
N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
[TBL] [Abstract][Full Text] [Related]
37. In vitro lymphocyte response to the phytomitogens in untreated and treated patients with Hodgkin's disease.
Romagnani S; Amadori A; Biti G; Bellesi G; Ricci M
Int Arch Allergy Appl Immunol; 1976; 51(3):378-89. PubMed ID: 1279027
[TBL] [Abstract][Full Text] [Related]
38. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
[TBL] [Abstract][Full Text] [Related]
39. [Case of implantation of human fetal thymus on the immunological reactivity in patients with Hodgkin's disease].
Pekić B; Dujić A; Radojicić B; Radojicić C; Kolasinović N; Martinović N; Susaković N; Radovanović L
Bilt Hematol Transfuz; 1975; 3(1-2):105-19. PubMed ID: 1225309
[TBL] [Abstract][Full Text] [Related]
40. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
